Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1,218.5 Million | USD 5,234.6 Million | 27.5% | 2021 |
FrequentlyAsked Questions
In the next years, demand for noninvasive diagnostic techniques is likely to increase due to the rising prevalence of chronic liver disorders. Over the projection period, the demand for noninvasive diagnostic tools is likely to increase along with patient awareness levels, which is expected to support the development of non-alcoholic steatohepatitis biomarkers.
According to the report, the global non-alcoholic steatohepatitis biomarkers market size was worth USD 1,218.5 million in 2021 and is estimated to grow to USD 5,234.6 million by 2028, with a compound annual growth rate (CAGR) of approximately 27.5% over the forecast period.
The market for non-alcoholic steatohepatitis biomarkers is expanding in North America due to a number of causes, including supportive government policies, the increased incidence of infectious disorders, cardiovascular conditions, and diabetes.
Some of the main competitors dominating the global non-alcoholic steatohepatitis biomarkers market include- Biopredictive, Quest Diagnostics, Exalenz Bioscience Ltd, GENFIT, Siemens Healthineers, ONE WAY LIVER, S.L, Prometheus Laboratories Inc, and Gilead Sciences Ltd.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed